
    
      Our primary hypothesis is that autologous M2 macrophage transplantation via intrathecal
      introduction is feasible and safe after non-acute stroke. Our secondary hypothesis is that
      autologous M2 macrophage transplantation is associated with improved neurological outcome
      after non-acute stroke
    
  